Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 18 02:03PM ET
1.04
Dollar change
-0.09
Percentage change
-7.67
%
Index- P/E- EPS (ttm)-0.24 Insider Own- Shs Outstand4.19M Perf Week1.96%
Market Cap4.36M Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-28.77%
Income-1.00M PEG- EPS next Q- Inst Own1.99% Short Float- Perf Quarter6.12%
Sales0.00M P/S- EPS this Y- Inst Trans0.32% Short Ratio0.08 Perf Half Y-
Book/sh-0.01 P/B- EPS next Y- ROA-108.60% Short Interest0.23M Perf Year-
Cash/sh0.00 P/C217.88 EPS next 5Y- ROE- 52W Range0.77 - 4.80 Perf YTD-52.07%
Dividend Est.- P/FCF- EPS past 5Y- ROI-449.10% 52W High-78.33% Beta-
Dividend TTM- Quick Ratio0.12 Sales past 5Y0.00% Gross Margin- 52W Low35.06% ATR (14)0.18
Dividend Ex-Date- Current Ratio0.12 EPS Y/Y TTM-163.82% Oper. Margin- RSI (14)40.25 Volatility9.17% 11.65%
Employees- Debt/Eq0.68 Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-208.13% Payout- Rel Volume0.02 Prev Close1.13
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume2.94M Price1.04
SMA20-15.51% SMA50-26.79% SMA200-20.43% Trades Volume42,812 Change-7.67%
Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.